VAP prevention â non-antimicrobial methods

More documents

Recommendations

Info

Stress ulcer prophylaxis & VAP VAP/CDT Bleeding Limit prophylaxis to high-risk patients: e.g. • Acute kidney injury/acute hepatic failure • Patients with INR >1.5, or platelets
Early vs. late tracheostomy to prevent VAP ‣ Day 6-8 vs. Day 13-15 ‣ [i.e. UK practice vs. US] Terragni PP et al, JAMA 2010; 303: 1483-7
Page 1 and 2: Monday 6 th September 2010 London V
Page 3 and 4: 1970 - 1980’s VAP is an iatrogeni
Page 5 and 6: Pepsin - in the lungs! • Intra-tr
Page 7 and 8: Supine body position as a risk fact
Page 9 and 10: Benefits seen in ‘Drakulovic’ t
Page 11 and 12: Oropharyngeal cleansing with 0.2% c
Page 13 and 14: Draft High Impact Intervention No 5
Page 15 and 16: Silver-coated ET tubes & VAP
Page 17 and 18: Silver-coated ET tubes & VAP VAP @
Page 19 and 20: Pneumonia in intubated patients: ro
Page 22 and 23: Subglottic Secretion Drainage Tubes
Page 24 and 25: Subglottic Secretion Drainage & VAP
Page 26 and 27: Kimberly-Clark £~15 ~£6 ~£10 Cov
Page 30 and 31: The UK TracMan trial N=909 Early (D
Page 32 and 33: Tight glucose control to prevent VA
Page 34 and 35: Tight glucose control to prevent VA
Page 36 and 37: Selective Decontamination to preven

VAP prevention â non-antimicrobial methods

Create successful ePaper yourself

Delete template?

Save as template?

VAP prevention â non-antimicrobial methods